US60783X1046 - Common Stock

We assign a fundamental rating of **2** out of 10 to **MODV**. **MODV** was compared to 114 industry peers in the **Health Care Providers & Services** industry. **MODV** may be in some trouble as it scores bad on both profitability and health. **MODV** has a correct valuation and a medium growth rate.

In the past year **MODV** was profitable.

In the past year **MODV** has reported a negative cash flow from operations.

In multiple years **MODV** reported negative operating cash flow during the last 5 years.

With a **Return On Assets** value of **-9.59%**, **MODV** is not doing good in the industry: **67.54%** of the companies in the same industry are doing better.

The **Return On Equity** of **MODV** (**-1689.29%**) is worse than **85.09%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -9.59% | ||

ROE | -1689.29% | ||

ROIC | 1.82% |

ROA(3y)-4.51%

ROA(5y)-2.36%

ROE(3y)-47.21%

ROE(5y)-26.92%

ROIC(3y)3.11%

ROIC(5y)4.49%

With a **Gross Margin** value of **15.73%**, **MODV** is not doing good in the industry: **68.42%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 1.07% | ||

PM (TTM) | N/A | ||

GM | 15.73% |

OM growth 3Y-46.23%

OM growth 5Y-13.75%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-7.58%

GM growth 5Y18.19%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **MODV** is destroying value.

The number of shares outstanding for **MODV** has been increased compared to 5 years ago.

Compared to 1 year ago, **MODV** has a worse debt to assets ratio.

Looking at the **Altman-Z score**, with a value of **1.65**, **MODV** is in line with its industry, outperforming **45.61%** of the companies in the same industry.

A Debt/Equity ratio of **122.86** is on the high side and indicates that **MODV** has dependencies on debt financing.

The **Debt to Equity ratio** of **MODV** (**122.86**) is worse than **85.09%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 122.86 | ||

Debt/FCF | N/A | ||

Altman-Z | 1.65 |

ROIC/WACC0.26

WACC7%

Looking at the **Current ratio**, with a value of **0.80**, **MODV** is doing worse than **80.70%** of the companies in the same industry.

A Quick Ratio of **0.80** indicates that **MODV** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.8 | ||

Quick Ratio | 0.8 |

The **Earnings Per Share** has been growing by **17.87%** on average over the past years. This is quite good.

The **Revenue** has been growing by **14.71%** on average over the past years. This is quite good.

EPS 1Y (TTM)-60.51%

EPS 3Y-6.06%

EPS 5Y17.87%

EPS Q2Q%-102.04%

Revenue 1Y (TTM)4.11%

Revenue growth 3Y26.2%

Revenue growth 5Y14.71%

Sales Q2Q%-0.12%

The **Revenue** is expected to grow by **5.16%** on average over the next years.

EPS Next Y-61.56%

EPS Next 2Y-7.1%

EPS Next 3Y5.19%

EPS Next 5YN/A

Revenue Next Year2.71%

Revenue Next 2Y5.05%

Revenue Next 3Y5.16%

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

Based on the **Price/Earnings** ratio of **12.26**, the valuation of **MODV** can be described as correct.

Based on the **Price/Earnings** ratio, **MODV** is valued cheaply inside the industry as 91.23% of the companies are valued more expensively.

The average S&P500 **Price/Earnings** ratio is at **29.62**. **MODV** is valued rather cheaply when compared to this.

The **Price/Forward Earnings** ratio is **6.60**, which indicates a rather cheap valuation of **MODV**.

Based on the **Price/Forward Earnings** ratio, **MODV** is valued cheaply inside the industry as 99.12% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 12.26 | ||

Fwd PE | 6.6 |

Based on the **Enterprise Value to EBITDA** ratio, **MODV** is valued a bit cheaper than 79.82% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 10.36 |

PEG (NY)N/A

PEG (5Y)0.69

EPS Next 2Y-7.1%

EPS Next 3Y5.19%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**MODIVCARE INC**

NASDAQ:MODV (9/6/2024, 8:00:02 PM)

After market: 32 0 (0%)**32**

**+0.62 (+1.98%) **

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap454.72M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 12.26 | ||

Fwd PE | 6.6 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.69

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -9.59% | ||

ROE | -1689.29% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 1.07% | ||

PM (TTM) | N/A | ||

GM | 15.73% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.65

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 122.86 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.8 | ||

Quick Ratio | 0.8 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-60.51%

EPS 3Y-6.06%

EPS 5Y

EPS Q2Q%

EPS Next Y-61.56%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)4.11%

Revenue growth 3Y26.2%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y